ApprovalTrail

Approval · Notice of Compliance 471 · 2003

KEMSOL: Notice of Compliance 471

Issued August 25, 2003

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
471
Date
August 25, 2003
Company
Axxess Pharma Inc.Markham, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Admin
Reason
Manufacturer name change
Therapeutic class
Topical agent for scleroderma treatment

Products in this notice

BrandDINStatus today
KEMSOL00376167Cancelled Post Market

Medicinal ingredients